Levocort Tablet 5 mg (Levocetirizine Hydrochloride)

Adult dose

Adults: Take 1 tablet (Levocetirizine Hydrochloride 5 mg) orally once daily, regardless of meals. For patients with renal impairment, the dosage should be adjusted based on kidney function (creatinine clearance). Dosage and frequency according to creatinine clearance (CLCR): - Mild (50 ≤ CLCR < 80): 1 tablet once daily - Moderate (30 ≤ CLCR < 50): 1 tablet every 2 days - Severe (10 ≤ C

Child dose

Children over 6 years: Take 1 tablet (Levocetirizine Hydrochloride 5 mg) orally once daily, regardless of meals.

This drug should not be used by patients who are allergic to specific ingredients or have previously had hypersensitivity to hydroxyzine or piperazine derivatives. It should not be administered to patients with severely impaired renal function or those undergoing dialysis, to pregnant women or those who may become pregnant, and to nursing mothers. This drug should not be used in infants under 1 year of age, and children under 6 years should be administered in liquid form rather than tablets. As this drug contains lactose, it should not be taken by patients with lactose intolerance or certain genetic lactose metabolism disorders. Patients with decreased kidney or liver function, and the elderly should be administered this drug with caution due to the possibility of elevated blood concentration. Symptoms such as drowsiness, fatigue, and dizziness may occur after taking this drug, so caution is advised when performing tasks that require concentration, such as driving or operating machinery. It is advisable to avoid concurrent use of this drug with alcohol or other medications that affect the central nervous system, as this may exacerbate drowsiness and decreased concentration. Patients at risk for urinary retention, such as those with spinal cord injury or prostate enlargement, should be particularly cautious when using this drug. This drug may cause various side effects, commonly including drowsiness, headache, nausea, abdominal pain, and skin rash. Rarely, severe allergic reactions or blood abnormalities have been reported. It is safer for pregnant or nursing women not to use this drug, and particularly while nursing, as the drug may be transmitted through breast milk. In pediatric patients, it should not be used in infants under 1 year, liquid form should be administered to those under 6 years, and the dosage for children under 12 years should be carefully adjusted. Elderly patients may experience increased drug concentration due to impaired kidney function, so a lower starting dose is recommended and close monitoring of their condition is necessary. This drug may affect the results of allergy tests, so it is advisable to stop taking it 3-5 days prior to testing. In case of overdose, symptoms such as drowsiness may occur, and as there is no specific antidote, it is important to receive treatment according to the symptoms. Additionally, this drug is not well removed by dialysis, so caution is needed in the case of overdose.

Serious side effects

• Urticaria
• anaphylactic shock
• angioedema
• edema
• respiratory distress
• urticaria
• hypertension

Mild side effects

• Drowsiness
• lethargy
• headache
• numbness
• malaise
• fatigue
• dizziness
• heaviness
• excitement
• thirst

This drug should be stored in a dark, tightly closed container and kept at temperatures between 1 and 30 degrees Celsius. Proper storage helps maintain the drug's effectiveness and prevent degradation.

Appearance

White or off-white oval film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle